Blood-based circulating biomarkers for prediction of immune-checkpoint inhibitors efficacy in renal cell carcinoma

• Main Authors: Loubna Omri (Author), Marie Naigeon (Author), Ronan Flippot (Author), Javier Gavira-Díaz (Author), Jesus Poveda-Ferriols (Author), Dan Nguyen (Author), Chaimae Abdi (Author), Alvaro Arroyo-Salgado (Author), Nathalie Chaput (Author), Guillermo de Velasco (Author), Laurence Albigès (Author), Lucía Carril-Ajuria (Author)
• Format: Book
• Published: Open Exploration Publishing Inc., 2024-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Immune checkpoint inhibitors (ICI)-based combinations have become the standard first-line treatment for advanced clear cell renal cell carcinoma (ccRCC). Despite significant improvements in survival and the achievement of sustained long-term responses, a subset of patients remains refractory to ICI,...